Optimal treatment determination on the basis of haematoma volume and intra-cerebral haemorrhage score in patients with hypertensive putaminal haemorrhages: a retrospective analysis of 310 patients

BMC Neurology

Chao You¹  Jianguo Xu¹  Hao Li¹  Xiang Wang¹  Jin Li¹  Yunhui Zen¹  Hao Liu¹ 

[1] Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guoxue Street, 610041 Chengdu, Sichuan, People's Republic of China

关键词: Intra-cerebral haemorrhage;    Surgical indication;    Intra-cerebral haemorrhage score;    Spontaneous putaminal haemorrhage;   

Others  :  848363
DOI  :  10.1186/1471-2377-14-141

 received in 2013-10-18, accepted in 2014-06-30,  发布年份 2014

【 摘 要 】

Background

Hypertensive putaminal haemorrhage comprises major part of intra-cerebral haemorrhages, with particularly high morbidity and mortality. However, the optimal treatments for these individuals remain controversial.

Methods

From June 2010 to August 2013, patients with hypertensive putaminal haemorrhages were treated in the Department of Neurosurgery, West China Hospital. Information regarding the age, signs of cerebral herniation, haematoma volume, intra-ventricular haemorrhage, intra-cerebral haemorrhage score and the treatments of each patient were analyzed retrospectively. The outcome was evaluated by the 30-day mortality rate.

Results

The 30-day mortality rate of the patients with haematomas volume greater than or equal to 30 ml and intra-cerebral haemorrhage scores of 1 or 2 was decreased in the surgical group compared with those in the conservative group (1.92% VS. 21.40%, OR = 0.072, p = 0.028; 15.40% VS. 33.3%, OR = 0.365, p = 0.248, respectively). The mortality rate of the patients with signs of cerebral herniation was not significantly different between the surgical and conservative groups (83.30% VS. 100%; p = 0.529). The intra-cerebral haemorrhage score was significantly associated with the 30-day mortality rate of patients with intra-cerebral haemorrhages (r = -0.798, p < 0.001).

Conclusion

Patients with basal ganglia haematomas volume greater than or equal to 30 ml and intra-cerebral haemorrhage scores of 1 or 2 could benefit from the surgical removal of haematomas. The intra-cerebral haemorrhage score can accurately predict the 30-day mortality rate of patients with hypertensive putaminal haemorrhages.

【 授权许可】

   
2014 Liu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344:1450-1460.
• [2]Waga S, Miyazaki M, Okada M, Tochio H, Matsushima , Tanaka Y: Hypertensive putaminal hemorrhage: analysis of 182 patients. SurgNeurol 1986, 26:159-166.
• [3]Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP: Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993, 24:796-800.
• [4]Houguang Z, Yu Z, Ling L, Xu H, Yinghong T, Yuping T, Wei H, Jianzhong X, Qiang D: A prospective controlled study: minimally invasive stereotactic puncture therapy versus conventional craniotomy in the treatment of acute intracerebral hemorrhage. BMC Neurol 2011, 11:76. BioMed Central Full Text
• [5]Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw DH: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387-397.
• [6]Kanaya H, Kuuoda K: Development in neurosurgical approaches to hypertensive intracerebral hemorrhage in Japan. In Intracerebral Hematomas. Edited by Kaufman HH. New York: Raven Press Ltd.; 1992.
• [7]Teernstra OPM, Evers SMAA, Lodder J, Leffers P, Franke CL, Blaauw G: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator – a multicenter randomized controlled trial (SICHPA). Stroke 2003, 34(4):968-974.
• [8]Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32:891-897.
• [9]Kothari RU, Brott T, Broderick JP, Barsan WG, Suaer LR, Zuccarello M, Khoury J: The ABCs of measuring intracerebral hemorrhagevolumes. Stroke 1996, 27:1304-1305.
• [10]Antic B, Rogonovic Z, Tadic R, Raicevic B: Indications for surgical treatment of hypertensive intracerebralsupratentorial hematomas. Vojnosanit Pregl 1991, 48:35-39.
• [11]Kaya RA, Türkmenoqlu O, Ziyal IM, Qizhong L, Jiyao J, Yongming Q: The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylviantreansinsular approach. SurgNeurol 2003, 59:176-183.
• [12]Jianwei G, Weigiao Z, Xiaohua Z, Qizhong L, Jiyao J, Yongming Q: Our experience of transsylvian-transinsular microsurgical approach to hypertensive putaminal hematomas. J Craniofac Surg 2009, 20:1097-1099.
• [13]Chen C-H, Lee H-C, Chuang H-C, Chen CC, Lee WY, Huang YI, Chu YT, Cho DY: Transsylvian-transinsular approach for the removal of basal ganglia hemorrhage under a modified intracerebral hemorrhage score. J Craniofac Surg 2013, 24:1388-1391.
• [14]Clarke JL, Johnston SC, Farrent M, Bernstein R, Tong D, Hemphill JC: External validation of the ICH score. Neurocrit Care 2004, 1(1):53-60.
• [15]Hemphill JC III, Farrent M, Neil TA, Neill TAJ: Prospectivevalidation of the ICHScore for 12-month functional outcome. Neurology 2009, 73(14):1088-1094.